×

Research and Markets: Chinese Markets for Ovarian Cancer Treatment Drugs Features Companies such as Zhuhai Union Pharmaceutical Co., Ltd and Beijing SL Pharmaceutical Co., Ltd

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/8zhdx6/chinese_markets) has announced the addition of the "Chinese Markets for Ovarian Cancer Treatment Drugs" report to their offering.

China's demand for ovarian cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.

Key Topics Covered:

I. INTRODUCTION

II. BUSINESS ENVIRONMENT

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

VI. MARKET ENTRY CHANNELS

VII. OVARIAN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

LIST OF TABLES

LIST OF CHARTS

Companies Mentioned

Beijing SL Pharmaceutical Co., Ltd

Yangtze River Pharmaceutical Group

Hangzhou Aoyipollen Pharmaceutical Co., Ltd.

Zhuhai Union Pharmaceutical Co., Ltd

Shandong Qilu Pharmaceutical Co., Ltd

Chengdu Minyi Pharmaceutical Co., Ltd

Henan Jiaozuo KL Pharmaceutical Co., Ltd

Changzhou Siyao Pharmaceutical Co., Ltd

For more information visit http://www.researchandmarkets.com/research/8zhdx6/chinese_markets

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Ovarian Cancer

Source: Research and Markets